Bio


Dr. Felix Chang's clinical practice mainly involves intraoperative neurophysiologic monitoring (IONM) and the treatment of neurological disorders with botulinum toxin. He earned his medical degree at the University of Texas Southwestern Medical Center. He completed his neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston. He then went on to complete a fellowship in clinical neurophysiology with a focus in intraoperative neurophysiologic monitoring at Stanford.

Clinical Focus


  • Intraoperative Neurophysiological Monitoring
  • Botulinum Toxin Treatment
  • Clinical Neurophysiology

Academic Appointments


Honors & Awards


  • Young Investigator Award, American Clinical Neurophysiology Society (2021)

Professional Education


  • Internship: George Washington University Medical Center Dept of Internal Medicine (2017) DC
  • Board Certification, American Board of Psychiatry and Neurology, Clinical Neurophysiology (2023)
  • Fellowship: Stanford Neurophysiology Fellowship (2021) CA
  • Board Certification: American Board of Psychiatry and Neurology, Neurology (2020)
  • Residency: Beth Israel Deaconess Medical Center Neurology Residency (2020) MA
  • Medical Education: University of Texas Southwestern Medical School Registrar (2016) TX
  • MD, University of Texas Southwestern (2016)

All Publications


  • Intraoperative Neurophysiologic Monitoring of Cerebrovascular Disorders Intraoperative Monitoring Lopez, J. R., Chang, F. W. Springer, Cham. 2022; 1: 611–659
  • Intraoperative Neurophysiologic Monitoring for Thoracic and Thoracoabdominal Aortic Procedures Intraoperative Monitoring Chang, F. W., Lopez, J. R. Springer, Cham. 2022; 1: 661–708